adult population take glucagon-like peptide-1 receptor agonists (GLP-1RAs) for chronic diseases or weight loss
Key Points Research into the effect of semaglutide on breastfeeding is still emerging, but initial studies suggest minimal risk to breastfed babies Oral semaglutide (Rybelsus), however, is specifically not recommended during breastfeeding While early evidence is reassuring, long-term effects on infants remain unknown Healthcare providers still recommend caution and individualized decision-making You've heard about semaglutide's impressive weight loss results
Min SH, Yoon J-H, Moon SJ, Hahn S, Cho YM
Particularly, liraglutide attenuates pre-established atherosclerosis throughout the aorta and aortic root in ApoE -/- mice via increasing macrophage polarization into anti-inflammatory macrophages and by reducing the number of pro-inflammatory macrophages [92]
1 and 4), multiple potential mechanisms of kidney protection have been described experimentally (e.g